U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Uterine corpus sarcoma

MedGen UID:
137837
•Concept ID:
C0338113
•
Neoplastic Process
Synonyms: Body of Uterus Sarcoma; body of uterus sarcoma; Corpus Uteri Sarcoma; corpus uteri sarcoma; Sarcoma of body of uterus; Sarcoma of Body of Uterus; sarcoma of body of uterus; Sarcoma of corpus uteri; Sarcoma of Corpus Uteri; sarcoma of corpus uteri; Sarcoma of the Body of Uterus; sarcoma of the body of uterus; Sarcoma of the Corpus Uteri; sarcoma of the corpus uteri; Sarcoma of the corpus uteri; Sarcoma of the Uterine Body; sarcoma of the uterine body; Sarcoma of the Uterine Corpus; sarcoma of the uterine corpus; Sarcoma of the Uterus; sarcoma of the uterus; Sarcoma of Uterine Body; sarcoma of uterine body; Sarcoma of Uterine Corpus; sarcoma of uterine corpus; Sarcoma of uterus; Sarcoma of Uterus; sarcoma of uterus; Uterine Body Sarcoma; uterine body sarcoma; Uterine Corpus Sarcoma; uterine corpus sarcoma; Uterine sarcoma; Uterine Sarcoma; uterine sarcoma; uterine sarcoma/mesenchymal; Uterus Sarcoma; uterus sarcoma
SNOMED CT: Uterine sarcoma (254877001); Sarcoma of uterus (254877001); Sarcoma of corpus uteri (1162311007); Sarcoma of body of uterus (1162311007)
 
Monarch Initiative: MONDO:0005210
Orphanet: ORPHA213620

Definition

A malignant mesenchymal neoplasm arising from the wall of the uterine corpus (uterine body). The most representative examples are leiomyosarcoma and endometrial stromal sarcoma. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVUterine corpus sarcoma
Follow this link to review classifications for Uterine corpus sarcoma in Orphanet.

Professional guidelines

PubMed

APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S, Li Y, Xu J, Shen L
Neurol Res 2024 Mar;46(3):227-242. Epub 2024 Jan 22 doi: 10.1080/01616412.2023.2287340. PMID: 38007705
Role of radiotherapy in the management of rare gynaecological cancers.
Morcet-Delattre R, Espenel S, Tas P, Chargari C, Escande A
Cancer Radiother 2023 Dec;27(8):778-788. Epub 2023 Nov 2 doi: 10.1016/j.canrad.2023.08.006. PMID: 37925347
Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.
Abu-Rustum N, Yashar C, Arend R, Barber E, Bradley K, Brooks R, Campos SM, Chino J, Chon HS, Chu C, Crispens MA, Damast S, Fisher CM, Frederick P, Gaffney DK, Giuntoli R, Han E, Holmes J, Howitt BE, Lea J, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Podoll M, Salani R, Schorge J, Siedel J, Sisodia R, Soliman P, Ueda S, Urban R, Wethington SL, Wyse E, Zanotti K, McMillian NR, Aggarwal S
J Natl Compr Canc Netw 2023 Feb;21(2):181-209. doi: 10.6004/jnccn.2023.0006. PMID: 36791750

Recent clinical studies

Etiology

Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer.
Horowitz NS, Dehdashti F, Herzog TJ, Rader JS, Powell MA, Gibb RK, Grigsby PW, Siegel BA, Mutch DG
Gynecol Oncol 2004 Dec;95(3):546-51. doi: 10.1016/j.ygyno.2004.08.009. PMID: 15581961

Diagnosis

Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer.
Horowitz NS, Dehdashti F, Herzog TJ, Rader JS, Powell MA, Gibb RK, Grigsby PW, Siegel BA, Mutch DG
Gynecol Oncol 2004 Dec;95(3):546-51. doi: 10.1016/j.ygyno.2004.08.009. PMID: 15581961

Therapy

Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer.
Horowitz NS, Dehdashti F, Herzog TJ, Rader JS, Powell MA, Gibb RK, Grigsby PW, Siegel BA, Mutch DG
Gynecol Oncol 2004 Dec;95(3):546-51. doi: 10.1016/j.ygyno.2004.08.009. PMID: 15581961

Prognosis

Gynecological cancer incidence in a hospital population in Saudi Arabia: the effect of foreign immigration over two decades.
Makoha FW, Raheem MA
J Obstet Gynaecol Res 2008 Aug;34(4):538-42. doi: 10.1111/j.1447-0756.2008.00735.x. PMID: 18937706
Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer.
Horowitz NS, Dehdashti F, Herzog TJ, Rader JS, Powell MA, Gibb RK, Grigsby PW, Siegel BA, Mutch DG
Gynecol Oncol 2004 Dec;95(3):546-51. doi: 10.1016/j.ygyno.2004.08.009. PMID: 15581961

Clinical prediction guides

Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer.
Horowitz NS, Dehdashti F, Herzog TJ, Rader JS, Powell MA, Gibb RK, Grigsby PW, Siegel BA, Mutch DG
Gynecol Oncol 2004 Dec;95(3):546-51. doi: 10.1016/j.ygyno.2004.08.009. PMID: 15581961

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Reviews

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...